VEGF inhibitors for the treatment of neovascular age-related macular degeneration

Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans

(2008) Tim U. Krohne et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1

(2008) Carl D. Regillo et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202)

(2008) Toshirou Nishida et al.   International Journal of Clinical Oncology

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

(2008) Mark E. Kleinman et al.   NATURE

Computerized Model of Cost-Utility Analysis for Treatment of Age-Related Macular Degeneration

(2008) E.C. Fletcher et al.   OPHTHALMOLOGY

CFH and LOC387715/ARMS2 Genotypes and Treatment with Antioxidants and Zinc for Age-Related Macular Degeneration

(2008) Michael L. Klein et al.   OPHTHALMOLOGY

Vitreous Levels of Bevacizumab and Vascular Endothelial Growth Factor-A in Patients with Choroidal Neovascularization

(2008) Qi Zhu et al.   OPHTHALMOLOGY